Pro-Dex, Inc.

Pro-Dex, Inc. (NASDAQ:PDEX) is a specialized medical device manufacturer founded in 1978 and headquartered in Irvine, California. The company went public in 1986 and has established itself as a niche player in the powered surgical instruments market. Pro-Dex primarily serves as an original equipment manufacturer (OEM) partner to larger medical device companies, designing and manufacturing precision surgical tools used in orthopedic, thoracic, and craniomaxillofacial procedures. The company has built its reputation on producing high-quality, autoclavable surgical instruments that meet the stringent requirements of modern operating rooms.

Based on the available financial data, Pro-Dex has experienced significant growth and volatility over recent years. The company's revenue has grown from $42 million in fiscal 2022 to approximately $64 million on an annualized basis through the first three quarters of fiscal 2025, representing strong top-line growth. The company has demonstrated improved operational efficiency, with EBITDA margins expanding and profitability becoming more consistent. However, cash flow generation has been inconsistent, with the company experiencing negative free cash flow in some quarters, particularly Q2 2025 with -$4.7 million, followed by a recovery to positive $574,000 in Q3 2025. Pro-Dex appears to be benefiting from increased demand for its specialized surgical instruments, likely driven by broader trends in minimally invasive surgery and the recovery in elective procedures following the COVID-19 pandemic. The company's focus on autoclavable, reusable surgical instruments aligns with healthcare facilities' emphasis on cost-effective, environmentally sustainable surgical tools. The stock price has experienced significant appreciation, rising from approximately $14.63 in fiscal 2023 to $67.30 in the most recent quarter, reflecting investor optimism about the company's growth prospects and market position. This price appreciation has led to higher valuation multiples across most metrics.